Renaissance Technologies LLC cut its holdings in shares of TriMas Co. (NASDAQ:TRS – Free Report) by 11.1% during the 4th quarter, Holdings Channel reports. The firm owned 187,300 shares of the industrial products company’s stock after selling 23,400 shares during the period. Renaissance Technologies LLC’s holdings in TriMas were worth $4,606,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently made changes to their positions in TRS. KLP Kapitalforvaltning AS bought a new position in TriMas during the 4th quarter worth $202,000. Quantbot Technologies LP increased its position in shares of TriMas by 203.5% in the fourth quarter. Quantbot Technologies LP now owns 11,978 shares of the industrial products company’s stock worth $295,000 after purchasing an additional 8,031 shares during the period. Wells Fargo & Company MN increased its position in shares of TriMas by 21.1% in the fourth quarter. Wells Fargo & Company MN now owns 37,729 shares of the industrial products company’s stock worth $928,000 after purchasing an additional 6,573 shares during the period. JPMorgan Chase & Co. raised its stake in TriMas by 3.3% in the third quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company’s stock valued at $982,000 after purchasing an additional 1,227 shares in the last quarter. Finally, Barclays PLC lifted its position in TriMas by 341.3% during the third quarter. Barclays PLC now owns 68,792 shares of the industrial products company’s stock worth $1,755,000 after purchasing an additional 53,203 shares during the period. 99.42% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other news, CFO Scott A. Mell sold 2,218 shares of TriMas stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $22.54, for a total transaction of $49,993.72. Following the sale, the chief financial officer now directly owns 26,288 shares of the company’s stock, valued at approximately $592,531.52. This trade represents a 7.78 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Jeffrey A. Fielkow bought 2,500 shares of TriMas stock in a transaction on Friday, February 28th. The shares were acquired at an average cost of $20.78 per share, for a total transaction of $51,950.00. Following the completion of the acquisition, the director now directly owns 11,013 shares in the company, valued at approximately $228,850.14. The trade was a 29.37 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders acquired 806,246 shares of company stock valued at $19,338,213. 14.20% of the stock is currently owned by corporate insiders.
TriMas Trading Down 1.8 %
TriMas Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 28th were given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date was Friday, February 28th. TriMas’s dividend payout ratio is presently 27.12%.
Wall Street Analysts Forecast Growth
Separately, BWS Financial reissued a “buy” rating and issued a $40.00 target price on shares of TriMas in a report on Friday, February 28th.
View Our Latest Report on TriMas
TriMas Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
See Also
- Five stocks we like better than TriMas
- What Are Dividends? Buy the Best Dividend Stocks
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- About the Markup Calculator
- Why Call Option Traders Are Targeting This Dividend ETF Now
- What Are Some of the Best Large-Cap Stocks to Buy?
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRS – Free Report).
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.